Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Keith S. Wood
Observed names:
K S Wood,
K. S. Wood,
K.S. Wood
Institution:
University of California, Los Angeles
Observed institutions:
Tulane University,
United States Department of Veterans Affairs,
University of California, Los Angeles,
UCLA Health
OpenAlex ID:
A5014722015
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
1987
·
L J Ignarro
, G M Buga
, et al.
·
Proceedings of the National Academy of Sciences
·
5,104
Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.
1987
·
L J Ignarro
, R E Byrns
, et al.
·
Circulation Research
·
1,174
Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle
1990
·
Louis J. Ignarro
, Peggy A. Bush
, et al.
·
Biochemical and Biophysical Research Communications
·
832
Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid.
1986
·
L J Ignarro
, R G Harbison
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
416
Activation of soluble guanylate cyclase by NO-hemoproteins involves NO-heme exchange. Comparison of heme-containing and heme-deficient enzyme forms.
1986
·
L J Ignarro
, J B Adams
, et al.
·
Journal of Biological Chemistry
·
273
Association between cyclic GMP accumulation and acetylcholine-elicited relaxation of bovine intrapulmonary artery.
1984
·
L J Ignarro
, T M Burke
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
267
Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation.
1988
·
L J Ignarro
, R E Byrns
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
234
Regulation of soluble guanylate cyclase activity by porphyrins and metalloporphyrins.
1984
·
L J Ignarro
, B Ballot
, et al.
·
Journal of Biological Chemistry
·
232
Activation of purified soluble guanylate cyclase by protoporphyrin IX.
1982
·
L J Ignarro
, K S Wood
, et al.
·
Proceedings of the National Academy of Sciences
·
208
Guanylate cyclase from bovine lung. A kinetic analysis of the regulation of the purified soluble enzyme by protoporphyrin IX, heme, and nitrosyl-heme.
1982
·
M S Wolin
, K S Wood
, et al.
·
Journal of Biological Chemistry
·
185
Vascular smooth muscle-derived relaxing factor (MDRF) and its close similarity to nitric oxide
1990
·
Keith S. Wood
, Georgette M. Buga
, et al.
·
Biochemical and Biophysical Research Communications
·
178
Endothelium-dependent modulation of cGMP levels and intrinsic smooth muscle tone in isolated bovine intrapulmonary artery and vein.
1987
·
L J Ignarro
, R E Byrns
, et al.
·
Circulation Research
·
154
PDF
Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and VIP
1987
·
L. J. Ignarro
, R. E. Byrns
, et al.
·
American Journal of Physiology-Heart and Circulatory Physiology
·
116
Purification and properties of heme-deficient hepatic soluble guanylate cyclase: Effects of heme and other factors on enzyme activation by NO, NO-heme, and protoporphyrin IX
1982
·
Eliot H. Ohlstein
, Keith S. Wood
, et al.
·
Archives of Biochemistry and Biophysics
·
105
Regulation of purified soluble guanylate cyclase by porphyrins and metalloporphyrins: a unifying concept.
1984
·
L J Ignarro
, K S Wood
, et al.
·
PubMed
·
100
Endothelium-derived nitric oxide relaxes nonvascular smooth muscle
1989
·
Georgette M. Buga
, Michele E. Gold
, et al.
·
European Journal of Pharmacology
·
99
Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle.
1988
·
L J Ignarro
, G M Buga
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
94
Characterization and actions of human umbilical endothelium derived relaxing factor
1991
·
G. Chaudhuri
, Georgette M. Buga
, et al.
·
British Journal of Pharmacology
·
79
PDF
Dissimilarities between methylene blue and cyanide on relaxation and cyclic GMP formation in endothelium-intact intrapulmonary artery caused by nitrogen oxide-containing vasodilators and acetylcholine.
1986
·
L J Ignarro
, R G Harbison
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
77
Antagonistic modulatory roles of magnesium and calcium on release of endothelium-derived relaxing factor and smooth muscle tone.
1990
·
M E Gold
, G M Buga
, et al.
·
Circulation Research
·
73
PDF
NG-Amino-L-arginine: A new potent antagonist of L-arginine-mediated endothelium-dependent relaxation
1990
·
Jon M. Fukuto
, Keith S. Wood
, et al.
·
Biochemical and Biophysical Research Communications
·
72
Basic polyamino acids rich in arginine, lysine, or ornithine cause both enhancement of and refractoriness to formation of endothelium-derived nitric oxide in pulmonary artery and vein.
1989
·
L J Ignarro
, M E Gold
, et al.
·
Circulation Research
·
68
PDF
NG-methyl-L-arginine causes endothelium-dependent contraction and inhibition of cyclic GMP formation in artery and vein.
1990
·
M E Gold
, K S Wood
, et al.
·
Proceedings of the National Academy of Sciences
·
66
L-Arginine causes whereas L-argininosuccinic acid inhibits endothelium-dependent vascular smooth muscle relaxation
1989
·
Michele E. Gold
, Keith S. Wood
, et al.
·
Biochemical and Biophysical Research Communications
·
63
Differences in responsiveness of intrapulmonary artery and vein to arachidonic acid: mechanism of arterial relaxation involves cyclic guanosine 3':5'-monophosphate and cyclic adenosine 3':5'-monophosphate.
1985
·
L J Ignarro
, R G Harbison
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
51
Show more works
View as search
Works count:
35
Citation count:
10,540
H-index:
29
I10-index:
30
Year
Topic
Type
